Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assays.

Autor: Butala-Flores E; BioAgilytix Labs, Durham, NC, USA. Elizabeth.butala@bioagilytix.com., Nguyen T; BioAgilytix Labs, Durham, NC, USA., Selvan N; Lexeo Therapeutics, New York, NY, USA., Armstrong L; BioAgilytix Labs, Durham, NC, USA., Miller M; BioAgilytix Labs, Durham, NC, USA., Kamen L; BioAgilytix Labs, Durham, NC, USA., Lester T; BioAgilytix Labs, Durham, NC, USA., Wernyj R; BioAgilytix Labs, Durham, NC, USA., Khanna R; Lexeo Therapeutics, New York, NY, USA., McNally J; BioAgilytix Labs, Durham, NC, USA., Hays A; BioAgilytix Labs, Durham, NC, USA.

Publikováno v: Pharmaceutical research [Pharm Res] 2023 Oct; Vol. 40 (10), pp. 2383-2397. Date of Electronic Publication: 2023 Oct 25.

Analysis of the Transcriptome: Regulation of Cancer Stemness in Breast Ductal Carcinoma In Situ by Vitamin D Compounds.

Autor: Shan NL; Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey., Minden A; Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey.; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey., Furmanski P; Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey.; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey., Bak MJ; Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey., Cai L; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.; Department of Biomedical Engineering, School of Engineering, Rutgers, The State University of New Jersey, New Brunswick, New Jersey., Wernyj R; Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey., Sargsyan D; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey., Cheng D; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey., Wu R; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey., Kuo HD; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey., Li SN; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey., Fang M; Environmental and Occupational Health Sciences Institute and School of Public Health, Rutgers, The State University of New Jersey, New Brunswick, New Jersey., Maehr H; Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey., Kong AN; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey., Suh N; Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey. nsuh@pharmacy.rutgers.edu.; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.

Publikováno v: Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2020 Aug; Vol. 13 (8), pp. 673-686. Date of Electronic Publication: 2020 May 28.

Expression of calbindin-D~2~8~k in C6 glial cells stabilizes intracellular calcium levels and protects against apoptosis induced by calcium ionophore and amyloid -peptide

Autor: Wernyj, R. P., Mattson, M. P., Christakos, S.

Publikováno v: Molecular Brain Research; 1999, Vol. 64 Issue: 1 p69-79, 11p

CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma.

Autor: Gerardo-Ramírez, Monserrat¹ (AUTHOR) monsemgr@hotmail.com, Keggenhoff, Friederike L.¹ (AUTHOR) f.keggenhoff@imb-mainz.de, Giam, Vanessa¹ (AUTHOR) vanessa.giam@outlook.com, Becker, Diana¹ (AUTHOR) beckerdi@uni-mainz.de, Groth, Marco² (AUTHOR) marco.groth@leibniz-fli.de, Hartmann, Nils³ (AUTHOR) nils.hartmann@unimedizin-mainz.de, Straub, Beate K.³ (AUTHOR) beate.straub@unimedizin-mainz.de, Morrison, Helen^2,4 (AUTHOR) helen.morrison@leibniz-fli.de, Galle, Peter R.¹ (AUTHOR) peter.galle@unimedizin-mainz.de, Marquardt, Jens U.⁵ (AUTHOR) jens.marquardt@uksh.de, Herrlich, Peter² (AUTHOR) peter.herrlich@leibniz-fli.de, Hartmann, Monika¹ (AUTHOR) monika.hartmann3@outlook.de

Publikováno v: International Journal of Molecular Sciences. Aug2022, Vol. 23 Issue 15, p8616-8616. 20p.

Evaluation of the Prognostic Value of Solute Carrier Family 34 Member 2 "SLC34A2" in Papillary Thyroid Carcinoma: An Immunohistochemical Study.

Autor: Hakim, Sarah Adel¹ (AUTHOR), Abd El Atti, Rasha Mohamed¹ (AUTHOR), Faheim, Reham Mohamed² (AUTHOR), Abou Gabal, Hoda Hassan¹ (AUTHOR)

Publikováno v: Analytical Cellular Pathology: Cellular Oncology. 7/15/2021, p1-10. 10p.